{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:23:20Z","timestamp":1698744200232},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T00:00:00Z","timestamp":1236297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> The risks of developing malignant melanoma (MM) include ultraviolet irradiation and genetic factors. To examine the contribution of rare and common variation within known MM genes in sporadic US MM patients, coding regions of known MM susceptibility genes [cyclin\u2010dependent kinase inhibitor 2A (<jats:italic>CDKN2A<\/jats:italic>), cyclin\u2010dependent kinase 4, melanocortin 1 receptor (<jats:italic>MC1R<\/jats:italic>) and tyrosinase (<jats:italic>TYR<\/jats:italic>)] were resequenced in 109\u2013135 MM cases. The significance of variants was examined by comparing their frequencies in 390 cancer\u2010free controls. Potential deleterious mutations in <jats:italic>CDKN2A<\/jats:italic> were found in two patients and two others had variants of unknown significance. Cases were more likely than controls to harbour the <jats:italic>MC1R<\/jats:italic>\u2018R\u2019 variants known or predicted to alter its function (<jats:italic>P<\/jats:italic>\u2003=\u20030.002), particularly the R160W variant (<jats:italic>P<\/jats:italic>\u2003=\u20030.0035). The associated <jats:italic>TYR<\/jats:italic> R402Q variant (rs1126809*A) was found in 29% of cases, similar to what has been described previously. One MM patient with a family history of MM, who had developed other skin cancers, was homozygous for a novel <jats:italic>TYR<\/jats:italic> variant (P406L) of unknown significance. Hence, rare variants in <jats:italic>TYR<\/jats:italic> may be important risk factors for skin cancer.<\/jats:p>","DOI":"10.1111\/j.1600-0625.2008.00807.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T07:24:07Z","timestamp":1236324247000},"page":"485-487","source":"Crossref","is-referenced-by-count":17,"title":["Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients"],"prefix":"10.1111","volume":"18","author":[{"given":"M.","family":"Laurin Council","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Helms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn A.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,8]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)61033-1"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2008.04.005"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-15"},{"key":"e_1_2_3_5_2","first-page":"9818","volume-title":"Cancer Research","author":"Goldstein A M","year":"2006"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0196-97"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.2.209"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20202"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e328014a2cd"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cmr.0000198454.11580.b5"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/319500"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh120"},{"key":"e_1_2_3_13_2","article-title":"The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population","author":"Brudnik U","year":"2008","journal-title":"Exp Dermatol"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/323412"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.161"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.163"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.23.2679"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2006.00361.x"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.011536"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23444.x"},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0935"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9030"},{"key":"e_1_2_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)03025-3"},{"key":"e_1_2_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi219"},{"key":"e_1_2_3_26_2","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","article-title":"Association of MC1R variants and risk of melanoma in melanoma\u2010prone families with CDKN2A mutations","volume":"14","author":"Goldstein A M","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22712"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.2008.00807.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.2008.00807.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T02:14:58Z","timestamp":1696990498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.2008.00807.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1600-0625.2008.00807.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00807.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,8]]}}}